ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, announced today that it has signed an expanded agreement with Davol Inc., a subsidiary of C.R. Bard Inc.
